[Immunologic investigations in children suffering from recurrent respiratory tract infections]

N Mahlaoui1

  • 1Unité d’immuno-hématologie et rhumatologie pédiatriques, Hôpital Necker-Enfants Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France.

Insights

Recurrent respiratory infections in children often indicate normal immune development, but primary immunodeficiency must be ruled out. Accurate diagnosis is crucial for appropriate care and management.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Context:

  • Recurrent respiratory tract infections (RRTIs) are frequent in pediatric consultations.
  • Most children exhibit normal, albeit delayed, immune system maturation.
  • Increased susceptibility to infections necessitates ruling out underlying pathologies like primary immunodeficiency.

Purpose:

  • To guide pediatricians in diagnosing the cause of recurrent respiratory infections.
  • To differentiate between normal immune maturation and primary immunodeficiency.
  • To emphasize the importance of accurate diagnosis for patient management.

Summary:

  • Medical history and physical examination guide laboratory testing for recurrent infections.
  • Interpreting test results requires consideration of age, vaccination status, and infection history.
  • Diagnosing primary immunodeficiency is critical for children with high susceptibility to infections.

Impact:

  • Facilitates precise diagnosis, distinguishing normal development from severe primary immunodeficiency.
  • Ensures children needing specialized medical care receive timely intervention.
  • Improves management strategies for pediatric recurrent respiratory tract infections.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...